Reuters logo
BRIEF-Basilea Pharmaceutica reports H1 net loss of CHF 19.4 million
August 14, 2014 / 5:25 AM / 3 years ago

BRIEF-Basilea Pharmaceutica reports H1 net loss of CHF 19.4 million

Aug 14 (Reuters) - Basilea Pharmaceutica AG : * Says reports 2014 half-year financials - ceftobiprole launch in Germany

planned for second half of 2014 * Says half-year cash position of CHF 245.9 million * Says H1 net loss CHF 19.4 million versus net loss CHF 17.3 million year ago * Says H1 contract revenue of CHF 20.2 million (H1 2013: CHF 20.4 million) * Confirms its unchanged guidance: total operating expenses for 2014 estimated

at CHF 8 to 9 million on average per month * Says H1 operating loss CHF 19.5 million versus operating loss CHF 17.4

million year ago * Says operating loss in 2014 is estimated at CHF 4 to 5 million on average per

month * Source text for Eikon * Further company coverage

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below